[EN] COMPOUNDS AND METHODS FOR PREVENTING, TREATING, OR AMELIORATING AIRWAY DISEASE<br/>[FR] COMPOSÉS ET MÉTHODES POUR PRÉVENIR, TRAITER OU AMÉLIORER UNE MALADIE DES VOIES RESPIRATOIRES
申请人:[en]THOMAS JEFFERSON UNIVERSITY
公开号:WO2022173743A1
公开(公告)日:2022-08-18
The β2-adrenergic receptor (β2AR) is a primary target in the treatment of airway diseases such as asthma and chronic obstructive pulmonary disease (COPD). Since β-agonist treatment of airway disease can have severe side effects, compounds that attenuate the side effects of β-agonists have been identified via their ability to inhibit β2AR interaction with β-arrestins. These compounds are specific for the β2AR and effectively protect against the desensitization observed with β-agonist treatment in model cells and airway tissue. The present disclosure provides compounds and methods for treating airway disease, such as but not limited to COPD and/or asthma.